Joseph R McDermott

2PUBLICATIONS
23CO-AUTHORS
Molecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 08, 2023
Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair Deficiencies.

Diana Restifo, Joseph R McDermott, Dusica Cvetkovic

|Jul 26, 2023
Preclinical Efficacy of LP-184, a Tumor Site Activated Synthetic Lethal Therapeutic, in Glioblastoma.

Bachchu Lal, Aditya Kulkarni, Joseph McDermott

Pageof 1